Keyword: David Brennan


6. AstraZeneca

AstraZeneca had a pretty rough few years of R&D setbacks and failures up until 2012, when its former chief, David Brennan, was all but pushed out as a result. But things seem to have steadied somewhat since Pascal Soriot took the helm.

Chutes & Ladders: Three key Valeant execs jump ship

A trio of top execs exit embattled Valeant, Genentech promotes Bill Anderson to CEO, and Alexion replaces its CEO and CFO amid an internal Soliris sales probe. Plus more hirings, firings and retirings throughout the industry.